Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Decibel Therapeutics Shares Encouraging Preclinical Data From Hearing Loss Gene Therapy Programs

Decibel Therapeutics Inc (NASDAQ:DBTX) announced the presentation of preclinical data on DB-OTO, its lead gene therapy product candidate.

  • DB-OTO is a dual-vector adeno-associated candidate designed to restore hearing to individuals with profound, congenital hearing loss caused by mutations of the otoferlin gene. 
  • DB-OTO uses a cell-selective promoter to control otoferlin transgene expression in hair cells to enable the ear to transmit sound to the brain and provide a hearing. 
  • Administration of DB-OTO resulted in the restoration of functional otoferlin protein in mice and dose scaling and distribution in non-human primates (NHPs). 
  • New data further characterized the expression of otoferlin over time following DB-OTO administration in mice and NHPs, demonstrating that otoferlin expression increased over the first several weeks before plateauing.
  • The Company also presented new data on its preclinical AAV.103 program to treat GJB2-related hearing loss and its preclinical AAV.104 program to treat stereocilin-related hearing loss through selective expression of stereocilin in outer hair cells. 
  • Decibel is developing DB-OTO, AAV.103, and AAV.104 in collaboration with Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Decibel retains global commercial rights in the three programs.
  • Related: Regeneron Extends Hearing Loss Gene Therapy pact With Decibel.
  • Price Action: DBTX shares traded 1.74% lower at $4.23 on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.